Peter Keeling of Diaceutics discusses the role personalized medicine can play, specifically the diagnostic, in adding value to a therapy and why pricing models need to be reviewed to reflect the value that complementary and companion diagnostics can have on the overall targeted therapy value.|Peter Keeling of Diaceutics discusses the role personalized medicine can play, specifically the diagnostic, in adding value to a therapy and why pricing models need to be reviewed to reflect the value that complementary and companion diagnostics can have on the overall targeted therapy value.
Diagnostics Ignored in Targeted Therapy Pricing, Access and Value
